Fact sheet: Woodford PatientCapTrt

Fund information

Fund name
Woodford Patient Capital Trust PLC ORD 1P
Fund company manager
Woodford Investment Management
Fund type
ITR
Fund manager(s)
Neil Woodford
since 21/04/2015
Fund objective
To achieve long-term capital growth through investing in a portfolio consisting predominantly of UK companies, both quoted and unquoted. The Company will aim to deliver a return in excess of 10% per annum over the longer term.
Benchmark
-
Investment style
Growth
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

-1.46 %

1 Year rank in sector

14/15

Sector

IT UK All Companies

Yield
-
Fund size

£ 751.7 m

FE Risk score

139

NAV

98.43

Discount/Premium

+-7.6501

Gearing

117

Top in sector

Holdings snapshot

  • UK
    80.85%
  • USA
    24.22%
  • Norway
    3.78%
  • Ireland
    2.11%
  • Switzerland
    0.96%
  • Health Care
    64.91%
  • Financials
    30.38%
  • Technology
    6.8%
  • Industrials
    6.66%
  • Telecommunications
    2.64%
  • UK Equities
    80.85%
  • US Equities
    24.22%
  • Norwegian Equities
    3.78%
  • Irish Equities
    2.11%
  • Swiss Equities
    0.96%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund-5.07 %-0.11 %-1.46 %0 %0 %
Sector2.83 %4.68 %18.97 %35.88 %75.74 %
Rank within sector14 / 1513 / 1514 / 15 / /
Quartile th4 th4 th4 th th th

Calendar performance

YTD-20172016201520142013
Fund-0.11 %-9.75 %0 %0 %0 %
Sector14.88 %3.81 %9.09 %-1.69 %31.32 %
Rank within sector13 / 1514 / 15 / / /
Quartile th4 th4 th th th th

Price movement

52 week high106
52 week low87.4
Current bid price90.45
Current offer price90.95
Current mid price90.9

Holdings by region

  • 80.85% UK
  • 24.22% USA
  • 3.78% Norway
  • 2.11% Ireland
  • 0.96% Switzerland
  • 0.55% Luxembourg
  • -12.47% Money Market

Holdings by sector

  • 64.91% Health Care
  • 30.38% Financials
  • 6.8% Technology
  • 6.66% Industrials
  • 2.64% Telecommunications
  • 0.82% Consumer Goods
  • 0.26% Basic Materials
  • -12.47% Money Market

Holdings by asset type

  • 80.85% UK Equities
  • 24.22% US Equities
  • 3.78% Norwegian Equities
  • 2.11% Irish Equities
  • 0.96% Swiss Equities
  • 0.55% Luxembourg Equities
  • -12.47% Money Market

Individual holdings

  • 16.2% PROTHENA CORP PLC
  • 11.8% PURPLEBRICKS GROUP PLC
  • 8.47% OXFORD NANOPORE
  • 7.21% IMMUNOCORE A
  • 4.24% THERAVANCE BIOPHARMA INC
  • 4.05% PROTON PARTNERS INTERNATIONAL
  • 3.92% MEREO BIOPHARMA GROUP LTD
  • 3.24% OXFORD SCIENCES INNOVATION
  • 2.77% ATOM BANK (UNQUOTED)
  • 2.64% GIGACLEAR LTD